Bimodal fibrosis in a novel mouse model of bleomycin-induced usual interstitial pneumonia
Idiopathic pulmonary fibrosis is pathologically represented by usual interstitial pneumonia (UIP). Conventional bleomycin models used to study pathogenic mechanisms of pulmonary fibrosis display transient inflammation and fibrosis, so their relevance to UIP is limited. We developed a novel chronic i...
Gespeichert in:
Veröffentlicht in: | Life science alliance 2022-01, Vol.5 (1), p.e202101059 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 1 |
container_start_page | e202101059 |
container_title | Life science alliance |
container_volume | 5 |
creator | Miura, Yoko Lam, Maggie Bourke, Jane E Kanazawa, Satoshi |
description | Idiopathic pulmonary fibrosis is pathologically represented by usual interstitial pneumonia (UIP). Conventional bleomycin models used to study pathogenic mechanisms of pulmonary fibrosis display transient inflammation and fibrosis, so their relevance to UIP is limited. We developed a novel chronic induced-UIP (iUIP) model, inducing fibrosis in D1CC×D1BC transgenic mice by intra-tracheal instillation of bleomycin mixed with microbubbles followed by sonoporation (BMS). A bimodal fibrotic lung disease was observed over 14 wk, with an acute phase similar to nonspecific interstitial pneumonia (NSIP), followed by partial remission and a chronic fibrotic phase with honeycombing similar to UIP. In this secondary phase, we observed poor vascularization despite elevated PDGFRβ expression. γ2PF- and MMP7-positive epithelial cells, consistent with an invasive phenotype, were predominantly adjacent to fibrotic areas. Most invasive cells were
and/or
positive. This iUIP mouse model displays key features of idiopathic pulmonary fibrosis and has identified potential mechanisms contributing to the onset of NSIP and progression to UIP. The model will provide a useful tool for the assessment of therapeutic interventions to oppose acute and chronic fibrosis. |
doi_str_mv | 10.26508/lsa.202101059 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8572746</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>34728556</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-976f1ceee8fea0fd9d792033967e1e705739cf3217d8ab43e91839b9894954ab3</originalsourceid><addsrcrecordid>eNpVkEtLxDAQx4Mo7rLu1aP0C3TNs2kugi6-YMGLHjyFtJlopE2Wpl3Yb2_wsSgM82Dm_x_4IXRO8IpWAteXXTIriinBBAt1hOZUSFESLOXxn36Glil9YIxpDi74KZoxLmktRDVHrze-j9Z0hfPNEJNPhQ-FKULcQVf0cUqQs819dEXTQez3rQ-lD3ZqwRZTmrLUhxGGNPrR52EbYOpj8OYMnTjTJVj-1AV6ubt9Xj-Um6f7x_X1pmy5qMZSycqRFgBqBwY7q6xUFDOmKgkEJBaSqdYxSqStTcMZKFIz1ahacSW4adgCXX37bqemB9tCGAfT6e3gezPsdTRe_98E_67f4k7XQlLJq2yw-jZoM4A0gDtoCdZfnHXmrA-cs-Di78fD-S9V9gnuU3tb</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Bimodal fibrosis in a novel mouse model of bleomycin-induced usual interstitial pneumonia</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Miura, Yoko ; Lam, Maggie ; Bourke, Jane E ; Kanazawa, Satoshi</creator><creatorcontrib>Miura, Yoko ; Lam, Maggie ; Bourke, Jane E ; Kanazawa, Satoshi</creatorcontrib><description>Idiopathic pulmonary fibrosis is pathologically represented by usual interstitial pneumonia (UIP). Conventional bleomycin models used to study pathogenic mechanisms of pulmonary fibrosis display transient inflammation and fibrosis, so their relevance to UIP is limited. We developed a novel chronic induced-UIP (iUIP) model, inducing fibrosis in D1CC×D1BC transgenic mice by intra-tracheal instillation of bleomycin mixed with microbubbles followed by sonoporation (BMS). A bimodal fibrotic lung disease was observed over 14 wk, with an acute phase similar to nonspecific interstitial pneumonia (NSIP), followed by partial remission and a chronic fibrotic phase with honeycombing similar to UIP. In this secondary phase, we observed poor vascularization despite elevated PDGFRβ expression. γ2PF- and MMP7-positive epithelial cells, consistent with an invasive phenotype, were predominantly adjacent to fibrotic areas. Most invasive cells were
and/or
positive. This iUIP mouse model displays key features of idiopathic pulmonary fibrosis and has identified potential mechanisms contributing to the onset of NSIP and progression to UIP. The model will provide a useful tool for the assessment of therapeutic interventions to oppose acute and chronic fibrosis.</description><identifier>ISSN: 2575-1077</identifier><identifier>EISSN: 2575-1077</identifier><identifier>DOI: 10.26508/lsa.202101059</identifier><identifier>PMID: 34728556</identifier><language>eng</language><publisher>United States: Life Science Alliance LLC</publisher><subject>Animals ; Biomarkers ; Biopsy ; Bleomycin - adverse effects ; Disease Models, Animal ; Disease Progression ; Disease Susceptibility ; DNA Damage ; Epithelial Cells - metabolism ; Epithelial Cells - pathology ; Fluorescent Antibody Technique ; Idiopathic Interstitial Pneumonias - etiology ; Idiopathic Interstitial Pneumonias - metabolism ; Idiopathic Interstitial Pneumonias - pathology ; Idiopathic Pulmonary Fibrosis - etiology ; Idiopathic Pulmonary Fibrosis - metabolism ; Idiopathic Pulmonary Fibrosis - pathology ; Immunohistochemistry ; Mice ; Mice, Transgenic</subject><ispartof>Life science alliance, 2022-01, Vol.5 (1), p.e202101059</ispartof><rights>2021 Miura et al.</rights><rights>2021 Miura et al. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-976f1ceee8fea0fd9d792033967e1e705739cf3217d8ab43e91839b9894954ab3</citedby><cites>FETCH-LOGICAL-c456t-976f1ceee8fea0fd9d792033967e1e705739cf3217d8ab43e91839b9894954ab3</cites><orcidid>0000-0003-0690-0993 ; 0000-0001-7314-9234</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572746/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572746/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34728556$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miura, Yoko</creatorcontrib><creatorcontrib>Lam, Maggie</creatorcontrib><creatorcontrib>Bourke, Jane E</creatorcontrib><creatorcontrib>Kanazawa, Satoshi</creatorcontrib><title>Bimodal fibrosis in a novel mouse model of bleomycin-induced usual interstitial pneumonia</title><title>Life science alliance</title><addtitle>Life Sci Alliance</addtitle><description>Idiopathic pulmonary fibrosis is pathologically represented by usual interstitial pneumonia (UIP). Conventional bleomycin models used to study pathogenic mechanisms of pulmonary fibrosis display transient inflammation and fibrosis, so their relevance to UIP is limited. We developed a novel chronic induced-UIP (iUIP) model, inducing fibrosis in D1CC×D1BC transgenic mice by intra-tracheal instillation of bleomycin mixed with microbubbles followed by sonoporation (BMS). A bimodal fibrotic lung disease was observed over 14 wk, with an acute phase similar to nonspecific interstitial pneumonia (NSIP), followed by partial remission and a chronic fibrotic phase with honeycombing similar to UIP. In this secondary phase, we observed poor vascularization despite elevated PDGFRβ expression. γ2PF- and MMP7-positive epithelial cells, consistent with an invasive phenotype, were predominantly adjacent to fibrotic areas. Most invasive cells were
and/or
positive. This iUIP mouse model displays key features of idiopathic pulmonary fibrosis and has identified potential mechanisms contributing to the onset of NSIP and progression to UIP. The model will provide a useful tool for the assessment of therapeutic interventions to oppose acute and chronic fibrosis.</description><subject>Animals</subject><subject>Biomarkers</subject><subject>Biopsy</subject><subject>Bleomycin - adverse effects</subject><subject>Disease Models, Animal</subject><subject>Disease Progression</subject><subject>Disease Susceptibility</subject><subject>DNA Damage</subject><subject>Epithelial Cells - metabolism</subject><subject>Epithelial Cells - pathology</subject><subject>Fluorescent Antibody Technique</subject><subject>Idiopathic Interstitial Pneumonias - etiology</subject><subject>Idiopathic Interstitial Pneumonias - metabolism</subject><subject>Idiopathic Interstitial Pneumonias - pathology</subject><subject>Idiopathic Pulmonary Fibrosis - etiology</subject><subject>Idiopathic Pulmonary Fibrosis - metabolism</subject><subject>Idiopathic Pulmonary Fibrosis - pathology</subject><subject>Immunohistochemistry</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><issn>2575-1077</issn><issn>2575-1077</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkEtLxDAQx4Mo7rLu1aP0C3TNs2kugi6-YMGLHjyFtJlopE2Wpl3Yb2_wsSgM82Dm_x_4IXRO8IpWAteXXTIriinBBAt1hOZUSFESLOXxn36Glil9YIxpDi74KZoxLmktRDVHrze-j9Z0hfPNEJNPhQ-FKULcQVf0cUqQs819dEXTQez3rQ-lD3ZqwRZTmrLUhxGGNPrR52EbYOpj8OYMnTjTJVj-1AV6ubt9Xj-Um6f7x_X1pmy5qMZSycqRFgBqBwY7q6xUFDOmKgkEJBaSqdYxSqStTcMZKFIz1ahacSW4adgCXX37bqemB9tCGAfT6e3gezPsdTRe_98E_67f4k7XQlLJq2yw-jZoM4A0gDtoCdZfnHXmrA-cs-Di78fD-S9V9gnuU3tb</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Miura, Yoko</creator><creator>Lam, Maggie</creator><creator>Bourke, Jane E</creator><creator>Kanazawa, Satoshi</creator><general>Life Science Alliance LLC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0690-0993</orcidid><orcidid>https://orcid.org/0000-0001-7314-9234</orcidid></search><sort><creationdate>20220101</creationdate><title>Bimodal fibrosis in a novel mouse model of bleomycin-induced usual interstitial pneumonia</title><author>Miura, Yoko ; Lam, Maggie ; Bourke, Jane E ; Kanazawa, Satoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-976f1ceee8fea0fd9d792033967e1e705739cf3217d8ab43e91839b9894954ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Biomarkers</topic><topic>Biopsy</topic><topic>Bleomycin - adverse effects</topic><topic>Disease Models, Animal</topic><topic>Disease Progression</topic><topic>Disease Susceptibility</topic><topic>DNA Damage</topic><topic>Epithelial Cells - metabolism</topic><topic>Epithelial Cells - pathology</topic><topic>Fluorescent Antibody Technique</topic><topic>Idiopathic Interstitial Pneumonias - etiology</topic><topic>Idiopathic Interstitial Pneumonias - metabolism</topic><topic>Idiopathic Interstitial Pneumonias - pathology</topic><topic>Idiopathic Pulmonary Fibrosis - etiology</topic><topic>Idiopathic Pulmonary Fibrosis - metabolism</topic><topic>Idiopathic Pulmonary Fibrosis - pathology</topic><topic>Immunohistochemistry</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miura, Yoko</creatorcontrib><creatorcontrib>Lam, Maggie</creatorcontrib><creatorcontrib>Bourke, Jane E</creatorcontrib><creatorcontrib>Kanazawa, Satoshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Life science alliance</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miura, Yoko</au><au>Lam, Maggie</au><au>Bourke, Jane E</au><au>Kanazawa, Satoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bimodal fibrosis in a novel mouse model of bleomycin-induced usual interstitial pneumonia</atitle><jtitle>Life science alliance</jtitle><addtitle>Life Sci Alliance</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>5</volume><issue>1</issue><spage>e202101059</spage><pages>e202101059-</pages><issn>2575-1077</issn><eissn>2575-1077</eissn><abstract>Idiopathic pulmonary fibrosis is pathologically represented by usual interstitial pneumonia (UIP). Conventional bleomycin models used to study pathogenic mechanisms of pulmonary fibrosis display transient inflammation and fibrosis, so their relevance to UIP is limited. We developed a novel chronic induced-UIP (iUIP) model, inducing fibrosis in D1CC×D1BC transgenic mice by intra-tracheal instillation of bleomycin mixed with microbubbles followed by sonoporation (BMS). A bimodal fibrotic lung disease was observed over 14 wk, with an acute phase similar to nonspecific interstitial pneumonia (NSIP), followed by partial remission and a chronic fibrotic phase with honeycombing similar to UIP. In this secondary phase, we observed poor vascularization despite elevated PDGFRβ expression. γ2PF- and MMP7-positive epithelial cells, consistent with an invasive phenotype, were predominantly adjacent to fibrotic areas. Most invasive cells were
and/or
positive. This iUIP mouse model displays key features of idiopathic pulmonary fibrosis and has identified potential mechanisms contributing to the onset of NSIP and progression to UIP. The model will provide a useful tool for the assessment of therapeutic interventions to oppose acute and chronic fibrosis.</abstract><cop>United States</cop><pub>Life Science Alliance LLC</pub><pmid>34728556</pmid><doi>10.26508/lsa.202101059</doi><orcidid>https://orcid.org/0000-0003-0690-0993</orcidid><orcidid>https://orcid.org/0000-0001-7314-9234</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2575-1077 |
ispartof | Life science alliance, 2022-01, Vol.5 (1), p.e202101059 |
issn | 2575-1077 2575-1077 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8572746 |
source | MEDLINE; DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Animals Biomarkers Biopsy Bleomycin - adverse effects Disease Models, Animal Disease Progression Disease Susceptibility DNA Damage Epithelial Cells - metabolism Epithelial Cells - pathology Fluorescent Antibody Technique Idiopathic Interstitial Pneumonias - etiology Idiopathic Interstitial Pneumonias - metabolism Idiopathic Interstitial Pneumonias - pathology Idiopathic Pulmonary Fibrosis - etiology Idiopathic Pulmonary Fibrosis - metabolism Idiopathic Pulmonary Fibrosis - pathology Immunohistochemistry Mice Mice, Transgenic |
title | Bimodal fibrosis in a novel mouse model of bleomycin-induced usual interstitial pneumonia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T10%3A48%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bimodal%20fibrosis%20in%20a%20novel%20mouse%20model%20of%20bleomycin-induced%20usual%20interstitial%20pneumonia&rft.jtitle=Life%20science%20alliance&rft.au=Miura,%20Yoko&rft.date=2022-01-01&rft.volume=5&rft.issue=1&rft.spage=e202101059&rft.pages=e202101059-&rft.issn=2575-1077&rft.eissn=2575-1077&rft_id=info:doi/10.26508/lsa.202101059&rft_dat=%3Cpubmed_cross%3E34728556%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34728556&rfr_iscdi=true |